The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review

Autor: Saunders, Hailey, Pham, Ba’, Loong, Desmond, Mishra, Sujata, Ashoor, Huda M., Antony, Jesmin, Darvesh, Nazia, Bains, Silkan K., Jamieson, Margaret, Plett, Donna, Trivedi, Srushhti, Yu, Catherine H., Straus, Sharon E., Tricco, Andrea C., Isaranuwatchai, Wanrudee
Zdroj: In Value in Health July 2022 25(7):1235-1252
Databáze: ScienceDirect
Externí odkaz: